ChiCTR2300077733 版本V1.1 版本创建时间2024/06/18 17:25:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300077733 

最近更新日期:

Date of Last Refreshed on:

2023-11-17 11:05:34 

注册时间:

Date of Registration:

2023-11-17 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

农村高血压管理中的经济激励与医生行为

Public title:

Financial incentives and physician behavior in hypertension management

注册题目简写:

English Acronym:

研究课题的正式科学名称:

农村高血压管理中的经济激励与医生行为

Scientific title:

Financial incentives and physician behavior in hypertension management

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

钟悦 

研究负责人:

王健 

Applicant:

Yue Zhong 

Study leader:

Jian Wang 

申请注册联系人电话:

Applicant telephone:

+86 131 6328 0676

研究负责人电话:

Study leader's telephone:

+86 138 6415 7135

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhongyue666@whu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

wangjian993@whu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省武汉市洪山区珞珈山街道经济与管理学院

研究负责人通讯地址:

湖北省武汉市洪山区珞珈山街道经济与管理学院A201

Applicant address:

School of Economics and Management, Wuhan University, Luojiashan Street, Hongshan District, Wuhan City, Hubei Province

Study leader's address:

A201, School of Economics and Management, Wuhan University, Luojiashan Street, Hongshan District, Wuhan City, Hubei Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

武汉大学

Applicant's institution:

Wuhan University

研究负责人所在单位:

武汉大学

Affiliation of the Leader:

Wuhan University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

WHU-HSS-IRB2023014

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

武汉大学人文社会科学伦理委员会

Name of the ethic committee:

The Ethics Committee of the Humanities and Social Sciences of Wuhan University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-08-30 00:00:00

伦理委员会联系人:

禹燕民

Contact Name of the ethic committee:

Yanmin Yu

伦理委员会联系地址:

湖北省武汉市武昌区八一路299号

Contact Address of the ethic committee:

No.299, Bayi Road, Wuchang District, Wuhan City, Hubei Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 27 6875 3569

伦理委员会联系人邮箱:

Contact email of the ethic committee:

yym615@126.com

研究实施负责(组长)单位:

武汉大学董辅礽经济社会发展研究院

Primary sponsor:

Dong Fureng Institute of Economic and Social Development, Wuhan University

研究实施负责(组长)单位地址:

湖北省武汉市洪山区珞珈山街道经济与管理学院A201

Primary sponsor's address:

A201, School of Economics and Management, Wuhan University, Luojiashan Street, Hongshan District, Wuhan City, Hubei Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

武汉

Country:

China

Province:

Hubei

City:

Wuhan

单位(医院):

武汉大学董辅礽经济社会发展研究院

具体地址:

湖北省武汉市武昌区八一路299号

Institution
hospital:

Dong Fureng Institute of Economic and Social Development, Wuhan University

Address:

No.299, Bayi Road, Wuchang District, Wuhan City, Hubei Province

经费或物资来源:

自筹

Source(s) of funding:

Self-raised

Target disease:

Hypertension

Target disease code:

研究类型:

卫生服务研究

Study type:

Health services reaserch

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本文从医生层面聚焦经济激励与高血压长期健康管理,针对乡村医生在高血压健康管理中存在的激励不足的问题,运用聚类随机田野实验的方法,研究经济激励对于乡村医生的高血压长期管理行为及高血压患者血压控制的影响。  

Objectives of Study:

We try to explore the impact of physician-level financial incentives on the hypertensive health care in rural area.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

我们将选取在乡村卫生院工作的全职医生作为被试,同时其管理的高血压患者参与者须满足以下纳入标准:a) 年龄为45-75岁; b) 具有医生确诊的高血压疾病; c) 在本地已生活了一年以上。

Inclusion criteria

Primary care physicians who work full-time in rural health centers and clinics are eligible to participate. The hypertensive patients should meet specific inclusion criteria. a) Age from 45 to 75; b) The patients with physician-diagnosed essential hypertension; c) Local residents who have been living in the city for over one year.

排除标准:

a)有医生诊断的中风、心肌梗死、心力衰竭、恶性肿瘤、常规肾透析或终末期肾病;b)有由医生诊断的继发性高血压病史;c)怀孕、哺乳或计划在六个月内怀孕的妇女;d)有意在六个月内离开。

Exclusion criteria:

a) Have a physician-diagnosed stroke, myocardial infarction, heart failure, malignancy, regular kidney dialysis, or end-stage renal disease; b) Have a history of secondary hypertension diagnosed by a physician; c) Women who are pregnant, breastfeeding, or planning to become pregnant within six months; d) Have the intention to leave your residence within six months.

研究实施时间:

Study execute time:

From 2023-12-01 00:00:00 To 2025-04-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-12-01 00:00:00 To 2024-04-01 00:00:00  

干预措施:

Interventions:

组别:

控制组

样本量:

100

Group:

Control Group

Sample size:

干预措施:

审计与反馈

干预措施代码:

Intervention:

Audit and feedback

Intervention code:

组别:

干预组1

样本量:

100

Group:

Intervention Group 1

Sample size:

干预措施:

收益框架的经济激励;审计与反馈

干预措施代码:

Intervention:

Gain-framed financial incentive; Audit and feedback

Intervention code:

组别:

干预组2

样本量:

100

Group:

Intervention Group 2

Sample size:

干预措施:

损失框架的经济激励;审计与反馈

干预措施代码:

Intervention:

Lost-framed financial incentive; Audit and feedback

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

 

Country:

China 

Province:

Shandong 

City:

 

单位(医院):

单县卫生院 

单位级别:

社区卫生服务中心 

Institution
hospital:

Health care center in Shan Countryf

Level of the institution:

Health Service Center

测量指标:

Outcomes:

指标中文名:

收缩压

指标类型:

主要指标

Outcome:

systolic pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

舒张压

指标类型:

主要指标

Outcome:

diastolic pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

高血压控制的比例

指标类型:

次要指标

Outcome:

Proportion of hypertension control

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医生的高血压护理表现(随访情况,患者满意度)

指标类型:

次要指标

Outcome:

Doctor's hypertension care performance (follow-up, patient satisfaction)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

患者自我报告的用药依从性

指标类型:

次要指标

Outcome:

Patient self-reported medication compliance

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 45 years
最大 Max age 75 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

按照分层随机的方法,由研究员将300名医生根据其就职医院和村卫生室的级别和规模进行分层,再在各中心内根据1:1:1的比例将医生随机分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Clustered RCT: Following a clustered random sampling method, researchers stratified 300 doctors based on the level and size of their affiliated hospitals and village clinics. Then, within each center, doctors were randomly assigned to groups in a 1:1:1 ratio.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

表格和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Record Form and EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-11-17 11:05:14